dantrolene has been researched along with Flaccid Quadriplegia in 7 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe a new case of eosinophilic pleural effusion induced by dantrolene chronic administration." | 8.82 | Dantrolene and pleural effusion: case report and review of literature. ( Calmels, P; Fayolle-Minon, I; Gautheron, V; Lê-Quang, B; Valayer-Chaléat, E, 2004) |
| "A 29-year-old man with C6 tetraplegia (ASIA A) using an implanted baclofen pump and intrathecal catheter infusion system for spasticity control developed severe spasticity, hyperthermia, hypotension, rhabdomyolysis, and disseminated intravascular coagulation after catheter disconnection." | 7.70 | Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. ( Christopherson, MW; Reeves, RK; Stolp-Smith, KA, 1998) |
| "A quadriplegic patient with severe spasticity, treated with dantrolene (400 mg daily) for 5 years, had dyspnea, orthopnea, hypoxia, and right-sided opacity of the chest on radiograph." | 5.31 | Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy. ( Felz, MW; Haviland-Foley, DJ, 2001) |
| "To describe a new case of eosinophilic pleural effusion induced by dantrolene chronic administration." | 4.82 | Dantrolene and pleural effusion: case report and review of literature. ( Calmels, P; Fayolle-Minon, I; Gautheron, V; Lê-Quang, B; Valayer-Chaléat, E, 2004) |
| "A 29-year-old man with C6 tetraplegia (ASIA A) using an implanted baclofen pump and intrathecal catheter infusion system for spasticity control developed severe spasticity, hyperthermia, hypotension, rhabdomyolysis, and disseminated intravascular coagulation after catheter disconnection." | 3.70 | Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. ( Christopherson, MW; Reeves, RK; Stolp-Smith, KA, 1998) |
| "A patient with C6D tetraplegia who sustained intoxication because of drug interaction is presented." | 1.33 | Carbamazepine toxicity following Oxybutynin and Dantrolene administration: a case report. ( Bluvstein, V; Catz, A; Odi, H; Ronen, J; Vander, T, 2005) |
| "A quadriplegic patient with severe spasticity, treated with dantrolene (400 mg daily) for 5 years, had dyspnea, orthopnea, hypoxia, and right-sided opacity of the chest on radiograph." | 1.31 | Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy. ( Felz, MW; Haviland-Foley, DJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lê-Quang, B | 1 |
| Calmels, P | 1 |
| Valayer-Chaléat, E | 1 |
| Fayolle-Minon, I | 1 |
| Gautheron, V | 1 |
| Vander, T | 1 |
| Odi, H | 1 |
| Bluvstein, V | 1 |
| Ronen, J | 1 |
| Catz, A | 1 |
| Gilman, TM | 1 |
| Segal, JL | 1 |
| Brunnemann, SR | 1 |
| Reeves, RK | 1 |
| Stolp-Smith, KA | 1 |
| Christopherson, MW | 1 |
| Felz, MW | 1 |
| Haviland-Foley, DJ | 1 |
| Pinder, RM | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| van Laere, M | 1 |
| Leus, P | 1 |
| Mastelinck, C | 1 |
2 reviews available for dantrolene and Flaccid Quadriplegia
| Article | Year |
|---|---|
Dantrolene and pleural effusion: case report and review of literature.
Topics: Dantrolene; Female; Humans; Middle Aged; Muscle Relaxants, Central; Muscle, Skeletal; Nitrofurantoin | 2004 |
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
Topics: Adult; Animals; Cats; Cerebral Palsy; Chemical and Drug Induced Liver Injury; Child; Clinical Trials | 1977 |
2 trials available for dantrolene and Flaccid Quadriplegia
| Article | Year |
|---|---|
Metoclopramide increases the bioavailability of dantrolene in spinal cord injury.
Topics: Administration, Oral; Adult; Biological Availability; Cross-Over Studies; Dantrolene; Dopamine Antag | 1996 |
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
Topics: Adult; Animals; Cats; Cerebral Palsy; Chemical and Drug Induced Liver Injury; Child; Clinical Trials | 1977 |
4 other studies available for dantrolene and Flaccid Quadriplegia
| Article | Year |
|---|---|
Carbamazepine toxicity following Oxybutynin and Dantrolene administration: a case report.
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Dantrolene; Dizziness; Drug Interactions; Drug Thera | 2005 |
Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure.
Topics: Adult; Baclofen; Catheters, Indwelling; Dantrolene; Disseminated Intravascular Coagulation; Equipmen | 1998 |
Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy.
Topics: Adult; Anti-Inflammatory Agents; Dantrolene; Drug Hypersensitivity; Eosinophilia; Humans; Male; Musc | 2001 |
[Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
Topics: Adolescent; Adult; Dantrolene; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Middle Aged; M | 1978 |